REFERENCES

__________________________________________ ______ ________________ C hap te r 7

Abd, A„ El-Bary, A., Geneidi, A.S,, Amin, S.Y., Ei~Ainan, A.A., 1998. Preparation and ptiarmacokinetic evaluation of carbamazepine controlled release solid dispersion granules, J. Drug Res. Egypt. 2 2 ,1 5 -3 1 ,

Aboelwafa, A,A., Fahmy, R,H,, 2010, A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design, Pharm, Dev, Technol,

Adel El-Egakey, M,, Soliva, M,, Speiser, P., 1971. Hot extruded dosage forms, Pharm. Acta Helv, 46, 31-52,

Ahuja, N,, Katare, 0 ,P ,, Singh, B,, 2007. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers, Eur. J, Pharm, Biopharm. 65(1), 26-38,

Aiedeh, K,M,, Khatib, H,A., Taha, M.O., Al-Zoubi, N,, 2006. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug, Pharmazie, 61(4), 306- 311,

Aitken-Nichol, C,, Zhan, F,, McGinity, J,W,, 1996, Hot melt extrusion of acrylic films, Pharm, Res. 13,804-808,

Akaike H, 1974, A new look at the statistical model identification, IEEE Trans Automat Control. 19,716-723.

Akbuga, J,, Gursoy, A.; Yetimoglu, F,, 1988, Preparation and properties of tablets prepared from furosemide-PVP solid dispersion systems, Drug Dev. Ind. Pharm. 14, 2091-2108.

Ai Omari, A.A., Al Omari, M.M.. Badwan, A.A., Al-Sou'od, K.A., 2010. Effect of cyclodextrlns on the solubility and stability of candesartan cilexetil in solution and solid state. J, Pharm. Biomed, Anal. [Epub ahead of print].

Al-Hamidi, H,, Edwards, A.A., Mohammad, M.A„ Nokhodchi, A., 2010. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf. B. Biointerfaces. 76(1), 170-8,

Al-Obaidi, H., Buckton, G,, 2009. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. AAPS Pharm. Sci. Tech, 10(4), 1172-1177.

Al-Razzak, L.A.; Dias, L.; Kaul, D.; Ghosh, S., 1997. Lipid based systems for oral delivery: Physiological, mechanistic, and product development perspectives. Symposia Abstracts and Biographies, AAPS Annual Meeting, Boston, 1997; AAPS, Alexandria, VA: p 18.

All, A.A., Gorashi, A.S., 1984. Absorption and dissolution of nitrofurantoin from different experimental formulations, Int, J. Pharm. 19 ,297-306,

Allen, L.V.J,, Yanchick, V,A„ Maness, D.D., 1977, Dissolution rates of corticosteriods utilizing sugar glass dispersions. J, Pharm, Sci. 66(4), 494-496.

3 3 4

_______ _____ _____________ _____

Anuta, V. Aldea A., Neagu 0 ., Mircioiu I., Miron D., Radulescu F,, Soare-Rada M., Enache, F „2007. Bioequivalence estimation based on peak areas of unicnown metabolites, Farmacia, 6,680-690,

Arias, M.J,, C3ines, J.IVl,, Moyano, J.R,, Perez-Barraies, M.J,, Vela, iVI.T., Rabasco, A.M., 1994. Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000, Eur, J, Drug Metab. Pharmacokinet. 19, 295-302.

Asker, A.F., Whitworth, C.W., 1975. Dissolution of acetylsalicylic acid from acetylsalicylic acid- polyethylene glycol 6000 coprecipitates. Pharmazie. 30, 530-535,

Asyarie, S., Rachmawati, H., 2007. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000. PDA J. Pharm. Sci, Technoi. 61(5), 400-410.

Aungst, B. J,, Nguyen, N. H., Rogers, N. J., Rowe, S, M,, Hussain, M. A., White, S. J,, Shum, L., 1997. Amphiphilic vehicles improve the oral bioavailabiltty of a poorly soluble H IV protease inhibitor at high doses, Int. J. Pharm. 156, 79-88,

Barzegar-Jalali, M., Maleki, N., Garjani, A., Khandar, A.A., Haji-Hosseinloo, M„ Jabbari, R., Dastmalchi, S. 2002. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Dev Ind. Pharm, 28, 681-686.

Bashiri-Shahroodi, A., Nassab, P.R., Szabo-Revesz, P., Rajko, R„ 2008, Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev. Ind. Pharm. 34(7), 781-788.

Bates, T. R. 1969. Dissolution characteristics of reserpine-polyvinylpyrrolidone co-precipitates, J. Pharm. Pharmacol, 21(10), 710-712,

Bayomi, M,A,, Abanumay, K,A,, Al-Angary, A,A,, 2002, Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Int. J, Pharm., 243(1-2), 107-117,

Berndl, G,, Breitenbach J„ Neumann, J., Reinhold, U., Rosenberg, J., Vollgraf, C. Zeidier, J„1998. Polymer/drug-melt extrusion: control of drug release and morphology in pharmaceutical formulations, American Association of Pharmaceutical Scientists, Annual Meeting Abstracts, San Francisco, p, 296,

Betageri, G.V., Makarla, K.R., 1995, Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques, Int. J. Pharm, 126 ,155-160 ,

Bhandari, K.H., Newa, M„ Kim, J.A., Yoo, B,K„ Woo, J,S„ Lyoo, W .S., Urn, H ,T„ Choi, H.G., Yong, C,S,, 2007, Preparation, characterization and evaluation of coenzyme Q IC binary solid dispersions for enhanced solubility and dissolution, Biol, Pharm. Bull, 30(6), 1171-1176.

Bloch, D,W., Speiser P.P., 1987. Solid dispersions - fundamentals and examples, Pharm. Acta Helv, 62, 23-27 ,

Borchart, H, J„ Daniels, F„ 1957, The application of differential thermal analysis to the study of reaction kinetics. J, Am, Chem. Soc, 79 ,41 -6 ,

Breitenbach, J,, 2002. Melt extrusion: from process to drug delivery technology. Eur, J. Pharm, Biopharm., 2002, 54(2), 107-117.

335

Breitenbach, J., 2002. Two concepts, one technology: controlled release and solid dispersion with Meltrexe, in: I. Ghebre-Selassie (Ed,), Modified Release Drug Delivery Technology, Marcel Dekker, New York, NY,

Breitenbach, J., Schrof, W,, Neumann, J,, 1999. Confocal Rannan spectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm. Res, 16(7), 1109-1113.

Broman, E., Khoo, C,, Taylor, L,S,, 2001. A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug, Int, J. Pharm. 222(1), 139-151.

Buckton, G,, Darcy, P., 1995, The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int. J. Pharm,, 123, 265-271.

Buehler V., 1993. Soluble Kollidon Grades (Povidone, Poiyvidone): Tablet Coatings, Kollidon: Polyvinylpyrrolidone for the Pharmaceutical Industry, BASF, Ludwigshafen. pp. 106-115.

Bugay, D,E„ 2001, Characterization of the solid-state: spectroscopic techniques. Adv. Drug Deliv. Rev, 48(1), 43-65.

Burnett, D.J., Thielmann, F., Booth, J., 2004. Determining the critical relative humidity for moisture-induced phase transitions. Int. J, Pharm. 2 8 7 (1 -2 ), 123-133,

Cade, D,, Madit, N,, 1996, Liquid filling in hard gelatin capsules - preliminary steps. Bull.Technique Gattefosse. 89,15-19.

Carcamo, E.C., Gana. I,M,, 1974, Eutectic mixtures and solid solutions of acetylsalicylic acid and urea. Stability of acetylsalicylic acid. An, R, Acad, Farm,, 40, 487-93,

Carr, R,L„ 1965, Evaluating Flow Properties of Solids. Chem, Eng, 7 2 ,1 6 3 -1 6 8 .

Carstensen, J.T., Chan, P.C., 1977, Flow rates and repose angles of wet Processed granulations, J, Pharm, Sci, 66(9), 1235-1238,

Chatham, S,M„ 1987. The use of bases in SSM formulations, S. T. P. Pharma. 3 ,5 7 5 -5 8 2 .

Chen, H., Jiang, G,, Ding, F,, 2009, Monolithic osmotic tablet containing solid dispersion of 10- hydroxycamptothecin. Drug Dev, Ind. Pharm. 35(2), 131-7,

Chen, J., Qiu, L., Hu, M„ Jin, Y., Han, J., 2008. Preparation, characterization and in vitroevaluation of solid dispersions containing docetaxel. Drug Dev, Ind. Pharm, 34(6), 588-594,

Chen, Y„ Li, G„ Huang, J,G„ Wang, R.H., Liu, H., Tang, R., 2009. Comparison of self- microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine, Yao Xue Xue Bao. 44(6), 658-66.

Chiou, W.L., 1977. PharmaceuticaJ applications of solid dispersion systems: X-ray diffraction and aqueous solubility studies on griseofuivin-polyethylene glycol 6000 systems. J. Pharm. Sci, 66(7), 989-991.

Chiou, W.L., Niazi, S, 1973. Differential thermal analysis and X-ray diffraction studies of

__________ ________ C h a p te r 7

336

C h a p te r 7

griseofulvin-succinic acid solid dispersions, J. Pharm, Sci. 62(3), 498-501 .

Chiou, W,L„ Niazi, S„ 1971. Phase diagram and dissolution-rate studies on sulfathiazole-urea solid dispersions. J, Ptnarm. Sci. 60(9), 1333-1338.

Chiou, W.L., Niazi, S „ 1976. Pharmaceutical applications of solid dispersion systems: dissolution of griseofulvin-succinic acid eutectic mixture. J. Pharm. Sci. 65(8), 1212-1224.

Chiou, W.L., Riegelman, S., 1969. Preparation and dissolution characteristics of several fast- release solid dispersions of griseofulvin, J. Pharm, Sci. 58(12),1505-1510.

Chiou, W.L., Riegelman, S., 1971. Increased dissolution rates of w ater' insoluble cardiac glycosides and steroids via solid dispersions in polyethylene glycol 6000, J. Pharm. Sci. 60(10), 1569-71,

Chiou, W,L,, Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J, Pharm, Sci, 60 ,1281-1302,

Cilurzo, F„ Minghetti, P,, Casiraghi, A„ Montanari, L., 2002. Characterization of nifedipine solid dispersions, Int, J, Pharm, 242(1-2), 313-317.

Cirri, M,, Maestrelli, P., Corti, G,. Mura, P., Vaileri, M., 2007. Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants. Drug Dellv, 14(4), 247-55,

Cole, E,T„ 1996, Equipment for filling and sealing liquids in hard gelatin capsules. Bull, Technique Gattefosse. 89 ,87-88 .

Collett. J.H., Flood, L., Sale, F.R., 1976. Some factors influencing dissolution from salicylic acid-urea solid dispersions, J, Pharm. Pharmacol. 28(4), 305-8.

Constantinides, P.P., 1995, Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res,, 12(11), 1561-72,

Corrigan, 0,1,, 1985, Mechanisms of dissolution of fast release solid dispersions. Drug Dev, Ind, Pharm., 11(3), 697-724.

Corrigan, 0.1,, Hoiohan, E,M., Sabra, K., 1984. Amorphous forms of thiazide diuretics prepared by spray-drying. Int. J. Pharm, 18,195-200,

Corrigan, 0,1,, Sabra, K., Hoiohan, E.M., 1983. Physicochemical properties of spray-dried drugs: Phenobarbitone and hydroflumethiazide. Drug Dev, Ind. Pharm, 9 ,1 -2 0 ,

Costantino, H.R., Firouzabadian, L , Wu, C„ Carrasquillo, K,G„ Griebenow, K., Zaie, S.E., Tracy, iVI.A., 2002. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J. Pharm. Sci, 91 (2), 388-395.

Craig, D.Q.M., 2002, The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231 (2), 131-44,

Craig, D.Q.IVl., Newton, J.M., 1991, Characterisation of polyethylene glycol solid dispersions using differential scanning calorimetry and solution calorimetry. Int, J, Pharm. 76 ,1 7 -2 4 ,

337

Crowley, K.J., Zografi, G,, 2002, W ater vapor absorption into amorphous hydrophobic drug/poly(vinyipyrrolidone) dispersions. J. Pharm. Sci. 91(10), 2150-2165,

Curatolo, W., 1998, Physical chemical properties of oral drug candidates in the discovery andexploratory development settings, Pharm, Sci. Tech, Today. 1(9), 387-393,

Cwiertnia, B„ 2008. Solubility of selected derivatives of 1,4-benzodiazepine-2-one in the presence of PVP, Acta. Pol, Pharm, 65(4), 487-91,

Daabis, N.A., Abd-Elfattah, S., El-Banna, H,M., 1974, Physicochemical study of drug binarysystems, 2, Khellin-urea system, Pharmazie. 29(6), 400-404,

Dahiya, S„ Pathak, K,, Sharma, R„ 2008, Development of extended release coevaporates and coprecipitates of promethazine HCI with acrylic polymers: formulation considerations, Chem, Pharm, Bull, (Tokyo), 56(4), 504-508,

Dahlberg, C,, Millqvist-Fureby, A,, Schuleit, M., Furo, I,, 2010. Polymer-drug interactions and wetting of solid dispersions. Eur. J. Pharm, Sci, 39(1-3), 125-33.

Damian, F,, Blaton, N,, Kinget, R., Van der Mooter, G., 2002, Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30, Int. J, Pharm, 244(1-2), 87-98,

Dang, Y.J., Hu, C,H,, An, L.N,, Zhu, G,Y,, 2010, Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000, Methods Find Exp. Clin, Pharmacol, 32(3), 157-62.

de Boer, A,H,, Molema, G,, Frijlink, H.W „ 2001. Pulmonary drug delivery: delivery to and through the lung, in: Molema G„ Meijer, D.F.K. (Eds), 2001. Drug targetting, organ specific strategies, Wiley-VCH, Weinheim, Germany, pp, 53-87,

De Meuter, P„ Rahier, H., Van Mele, B., 1999. The use of modulated temperature differentialscanning calorimetry for the characterisation of food systems. Int. J. Pharm,, 192(1), 77-84.

Deepti, Dureja, H,, Madan, A.K., 2007, Solid dispersion adsorbates for enhancement of dissolution rates of drugs, PDA J, Pharm, Sci. Technol. 61(2), 97-101,

Dennis, A. B„ Farr, S,J., Kellaway, I.W„ Taylor, G,, Davidson, R„ 1990, In vivo evaluation ofrapid release and sustained release Gelucire capsule formulations. Int. J. Pharm. 65, 85-100.

Desai, J,, Alexander, K., Riga, A., 2006. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int, J. Pharm. 308(1-2), 115-123.

Dhumal, R.S., Shimpi, S.L., Paradkar, A,R., 2007. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers. Acta. Pharm. 57(3), 287- 300.

Dittgen M., Graeser, T., Kaufmann, G., Gerecke, H,, Osterwaid, H., Oettel, M., 1995b Hot spin mixing: a new technology to manufacture solid dispersions- part 2: dienogest. Pharmazie, 50, 50-51.

______________________ _____________________________________________________________ Chaptej^ 7

338

Dittgen, M., Fricke, S., Gerecke, H„ Osterwald, H., 1996a, Hot spin mixing: a new technology to manufacture solid dispersions- part 1: testosterone. Pharmazie, 50 ,225 -22 6 .

Dittgen, M,, Fricke, S., Gerecke, H., Osterwald, H„ 1995c, Hot spin mixing: a new technology to manufacture solid dispersions- part 3: progesterone. Pharmazie. 50 ,507 -508 ,

Doelker M., Adel El-Egakey M., Soliva M,, Speiser P„ 1971, Hot extruded dosage forms. Pharm.Acta Helv. 46 (1 9 7 1 )3 1 -5 2 .

Doherty C., York P.J., 1987. Evidence for solid and liquid-state interactions in a furosemide- polyvinylpyrrolidone solid dispersion, J. Pharm. Sci. 7 6 ,7 3 1 -7 3 7 ,

Doherty, C, and York, P., 1989. The in-vitro pH-dlssolution dependence and in- vivo bioavailability of frusemide-PVP solid dispersions. J. Pharm. Pharmacol, 41(2), 73-8.

Dordunoo, S,K,, Ford, J,L„ Rubinstein, M.H., 1991, Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or Gelucire 44/14 for liquid filling of hard gelatin capsules. Drug Dev. Ind, Pharm, 17 ,1685-1713,

Dordunoo, S.K., Ford, J.L., Rubinstein, M,H,, 1997, Physical stability of solid dispersions containing triamterene or temazepam in poly(ethyleneglycol)s, J. Pharm. Pharmacol, 49, 390- 396,

Douroumis, D,, Bouropoulos, N,, Fahr, A., 2007. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method, J, Pharm, Pharmacol, 59(5), 645-653,

Doyle, E„ Spence, A.A., 1995. Cannabis as a medicine? Br. J. Anaesth, 74(4), 359-61.

Dresser, G.K„ Bailey, D,G„ Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J., Kim, R.B,, 2002. Fruit juices inhibit organic anion transporting-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 71(1), 11-20.

Drug Dev Ind Pharm, 2010;36(6):681-7, In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. He H, Yang R, Tang X.

Dubois, J .L , Ford, J.L., 1985, Similarities in the release rates of different drugs from polyethylene glycol 6000 solid dispersions, J, Pharm, Pharmacol. 37, 494-495,

Duclos, R,, Grenet, J,, Saiter, J.M,, Besancuon, P,, OrecchionI, A,M ,, 1990. Effect of aging on progesterone-poly(ethylene glycol) 6000 dispersions. X-ray study. Drug Dev, Ind, Pharm. 16, 255-265.

El-Banna, H,M„ Abd-Elfallah, 8,, Daabis, N.A,, 1974, Physicochemical study of drug binary systems. I. Phenobarbital-urea system, Pharmazie, 29(6), 396-400,

El-Sanna, H,M., Daabis, N.A,, Mortada, L.M., Abd-Elfattah, S., 1975. Physicochemical study of drug binary systems. Part 3: Tolbutamide 'urea and tolbutamide-mannitol systems, Pharmazie, 30(12), 788- 792,

El-Zein, H„ Riad, L., El-Bary, A,A,, 1998, Enhancement of carbamazepine dissolution: in-vitro and in-vivo evaluation, Int. J, Pharm, 168, 209- 220,

_____________ ____________________ ______________________ _________ ____________________ C h a p te rJ

339

Engers, D,, Teng, J,, Jirnenez-Novoa, J., Gent, P., Hossack, S„ Campbell, C,, Thomson, J., Ivanisevic, I,, Templeton, A,, E5yrn, S„ Newman, A., 2010. A solid-state approach to enable early development compounds: selection and animal bioavailability studies of an itraconazole amorphous solid dispersion. J. Pharm, Sci, 99(9), 3901-3922.

Eriksson, H.J.C., Hinrichs, W,L„ van Veen, B,, Somsen, G.W., de Jong, G.J., Frijlink, H.W.. 2002, Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase, Int. J, Pharm, 249(1-2), 59-70.

Erlich, L., Yu, D., Pallister, D.A., Levinson, R.S., Gole, D.G., Wilkinson, P.A., Erlich, R.E., Reeve, L.E., Viegas, T.X.. 1999, Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules. Int. J. Pharm. 179(1), 49-53.

Etter M.C., 1990. Hydrogen bond directed CO-crystallization and nnolecular recognition properties of diarylureas, J. Am. Chem. Soc. 112, 8415 -8426 .

Fawaz, F,, Bonini, F,, Guyot, M., Bildet, J., Maury M., Lagueny, A.M., 1996. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. Int. J, Pharm. 132,271-275.

Fernandez, M., Rodriguez, I.C., Margarit, IVI.V., Cerezo, A., 1992. Characterization of solid dispersions of piroxicam/polyelhyiene glycol 4000. Int. J. Pharm. 84 ,197 -20 2 .

Fini, A., Cavallari, C., Ospitali, F., 2008, Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Eur, J. Pharm, Biopharm. 70(1), 409-420,

Finn, A,, Straughn, A., Meyer, M., Chubb, J., 1987. Effect of dose and food on the bioavailability of cefuroxime axetil, Biopharm Drug Dispos. 8(6), 519-526.

Finn, A„ Straughn, A., Meyer, M„ Chubb, J„ 1987. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Disp. 8(6), 519 -52 6 .

Follonier, N., Doelker, E., Cole, E.T., 1995. Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials. J. Contr. Rel, 36. 243-250,

Ford, J„ Rubinstein, M.H., 1978. Phase equilibria and dissolution rates of indometliadn- polyethylene glycol 6000 solid dispersions. Pharm. Acta. Helv, 53(11), 327-332.

Ford, J.L., 1986. The current status of solid dispersions, Pharm. Acta. Helv. 61, 6 9 -8 8 .

Ford, J.L., Elliott, P.N.C., 1985. The effect of particle size on some in vitro and in vivo properties of indomethacin-poly(ethylene glycol) 6000 solid dispersions. Drug Dev, Ind. Pharm,11,537-549,

Ford, J,L„ Rubinstein, M.H., 1980. Formulation and ageing of tablets prepared fronn indomethacin-polyethylene glycol 6000 solid dispersions. Pharm. Acta. Helv. 55(1), 1-7.

Ford, J.L., Rubinstein, M.H., 1981. Preparation properties and aging of tables prepared from the chlorpropamide-urea solid dispersion. Int. J. Pharm. 8 ,311 -322 .

Ford, J.L., Stewart, A.F., Dubois J.L., 1986. The properties of solid dispersions of indomethacin

C h a p te r 7

340

C h a p te r 7

or phenylbutazone in polyethylene glycol, Int, J. Pharm. 28, 11-22.

Ford, J.L„ Stewart, A.F., Rubinstein, M,H,, 1979, The assay and stability of chlorpropamide in solid dispersion with urea, J, Pharm, Pharmacol. 31(11), 726-729.

Forster A,, Hempenstall, J., Tucker, I., Rades, T., 2001, Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int, J, Pharm, 226, 147-161,

Forster, A,, Hempenstall, J., Rades, T,, 2001. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J, Pharm. Pharmacol, 53(3), 303-315,

Forster, A., Hempenstall, J., Tucker, l„ Rades, T., 2001a, The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev. Ind. Pharm. 27(6), 549-560.

Forster, A., Hempenstall, J., Tucker, I., Rades, T., 2001b. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis, Int. J. Pharm. 226(1-2), 147-161,

Francois, D,, Jones, B,E„ 1978, The hard capsule with the soft center. European Capsule Technology Symposium, Constance. P. 55-61.

Froemming, K.H., Simons, B., Haase, J„ Hosemann, R., 1978, Problems of preparation, processing and storage of melt-embedded polyethylene glycol products. Pharm. Ind, 40, 967- 970,

Fukuoka E,, 1989, Glassy state of pharmaceuticals, Chem. Pharm. Bull, 37, 1047-1050 ,

Fukushima, K„ Haraya, K„ Terasaka, S„ Ito, Y,, Sugioka, N., Takada, K,, 2008, Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats, Biol. Pharm, Bull, 31(6), 1209-1214,

Fukushima, K., Terasaka, S., Haraya, K., Kodera, S., Seki, Y., W ada, A., Ito, Y„ Shibata, N., Sugioka, N., Takada, K., 2007, Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system, Biol, Pharm, Bull, 30(4), 733-738.

Gandhi, P., Momin, N„ Kharade, S„ Konapure, N.P., Kuchekar B.S., 2006, Spectrophotometric Estimation of Acyclovir in Pharmaceutical Dosage Forms Indian J. Pharm, Sci, 68(4), 516-517.

Garcia, M.C., 2005. The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry. J, Chromatogr. B Analyt, Technol. Biomed, Life Sci, 825(2), 111-123.

Geneidi, A.S., Ali, A,A., Salama, R,B„ 1978. Solid dispersions of nitrofurantoin, ethotoin and coumarin with polyethylene glycol 6000 and their coprecipitates with providone 25000. J, Pharm, Sci. 67(1), 114-116,

341

Ghanem, A„ Meshali, M., Ibraheem, Y., 1980. Dissolution rates of suifamethoxazole utilizing sugar glass dispersion, J, Pharm, Pharniacal. 32(10), 675-7,

Ghareeb, M.M., Abdulrasool, A.A., Hussein, A,A., Noordin, M.I., 2009 Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS Pharm. Sci. Tech. 10(4), 1206-15,

Ghebre-Selassie, I,, 1997. Solid pharmaceutical dosage forms in form of a particulate dispersion, Eur, Patent, 1,011,640.

Ghebremeskel, A.N., Vemavarapu, C., Lodaya, M., 2000b. Pharm. Res. 23(8), 1928-1936, Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API; stability testing of selected solid dispersions.

Ghebremeskel, A.N., Vemavarapu, C., Lodaya, M., 2007, Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int. J, Pharm. 328(2), 119-29.

Gidwani, R.N., Anderson, A.J., 1976. An in vitro evaluation of methisazone solid dispersions. Can. J. Pharm. Sci. 11 ,117 -20 ,

Gines, J.M., Arias, M.J., Moyano, J.R., Sanchezsoto, P.J., 1996. Thermal investigation of crystallization of polyethylene glycols in solid dispersions containing oxazepam. Int. J, Pharm, 143, 247-253.

Girl, T.K., Sa, B., 2009. Statistical evaluation of influence of polymers concentration on disintegration time and diazepam release from quick-disintegrating rapid release tablet. Yakugaku Zasshi. 2009;129(9):1069-75.

Goddeeris, C„ Willems, T., Houthoofd, K,, Martens, J.A., Van den Mooter, G., 2008. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100, Eur. J. Pharm. Biopharm. 70(3), 861-868.

Goddeeris, C., Willems, T., Van den Mooter, G., 2008, Formulation of fast disintegrating tabletsof ternary solid dispersions consisting of TPGS 1000 and HPM C 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur. J. Pharm. Sci. 34(4-5), 293-302,

Gohel, M. C., Patel, L.D., 2003. Processing of nimesulide-PEG 400-P G -PV P solid dispersions: preparation, characterization and in vitro dissolution. Drug Dev. Ind. Pharm. 29(3), 299-310.

Goldberg, A.H., Gibaldi, M., Kanig, J.L., 1965. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I- Theoretical considerations and discussion of the literature. J, Pharm. Sci. 54(8), 1145-8,

Goldberg, A.H., Gibaldi, M., Kanig, J.L., 1966a. Increasing dissolution rates andgastrointestinal absorption of drugs via solid solutions and eutectic mixtures II- experimental evaluation of a eutectic mixture: urea-acetaminophen system. J, Pharm, Sci, 5 5 ,4 8 2 4 8 7 .

Goldberg, A.H., Gibaldi, M., Kanig, J .L , 1966b. Increasing dissolution rates andgastrointestinal absorption of drugs via solid solutions and eutectic mixtures III- experimental evaluation of griseofulvin-succinic acid solid solution, J. Pharm, Sci. 5 5 ,487 -49 2 .

__________ ______________ C h a p te r 7

342

Goldberg, A.H., Gibaldi, M., Kanig, J,L,, Mayersohn, M., 1966c, Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures IV- chloramphenicol-urea system, J, Pharm. Sci. 55, 581-v583.

Greenhaigh, D.J,, Williams, A.C,, Timmins, P„ York, P„ 1999, Solubility parameters as predictors of miscibiiity in solid dispersions, J. Pharm. Sci, 88(11), 1182-90,

Grotenhermen, F,, 2003, Pfiarmacokinetics and pharmacodynamics of cannabinoids, Clin, Pharmacokin, 42(4), 327-60,

Grunhagen H,H,, 1996, Polymer/drug-melt extrusion: therapeutic and technological appeal, Pharm ,Tech, E u r,8 , 22 -28 .

Guillaume, F., Guyot-Herman, A,M,, Duclos, R,, Besancuon, P,, Orechioni, A.M,, Drache, M., Conflant, P,, Gadefait, A,, Becourt, P„ 1992, Elaboration and physical study of an oxodipine solid dispersion in order to formulate tablets. Drug Dev, Ind. Pharm, 18, 811-827,

Guinot, S,, Leveiller, F„ 1999, The use of M TDSC to assess the amorphous phase content of a micronized drug substance, Int, J. Pharm, 192(1), 63-75.

Gupta, V., Gupta, M,, Madan, A,K., 2009. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug. PDA J. Pharm. Sci. Technol, 63(1), 58- 70,

Hahn, L,, Sucker, H„ 1989. Solid surfactant solutions of active ingredients in sugar esters. Pharm. Res., 1989, 6(11), 958-60,

Hamaura, T., Newton, J.M., 1999. Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol. J, Pharm. Sci, 8 8 ,1 2 2 8 -1 2 3 3 ,

Hamza Yel, S., Aburahma, M.H., 2010. Innovation of novel sustained release compression- coated tablets for lornoxicam: formulation and in vitro investigations. Drug Dev, Ind. Pharm. 36(3), 337-49.

Han, L.M., Guo, J,, Zhang, L.J., Wang, Q.S,, Fang, X ,L , 2006. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123. Acta, Pharmacol. Sin. 27(6), 747-753.

Hancock, B.C., Parks, M., 2000. W hat is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res, 17(4), 397-404.

Hancock, B,G,, Zografi, G„ 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm, Sci. 86(1), 1 -1 2 .

Hancok, B.C., Shamblin, S.L., Zografi, G., 1995. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures, Pharm, Res, 12, 799 -80 6 ,

Harwood, R.J., Johnson, J,L., 1994, Hydroxypropylcellulose, in: A. W ade, P.J, W eller (Eds,), 1994. Handbook of Pharmaceutical Excipients, American Pharmaceutical Association/The Pharmaceutical Press, Washington, DC/London, pp, 223-228,

C h a p t e r 7

343

Hasegawa, A,, Kawamura, R„ Nakagawa, H„ Sugimoto, I,, 1985. Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem. Pharm, Bull, 33, 3429-3435,

Hempenstalf, J,, 1997. Latest developments in tablet and capsule formulation, European Continuing Education College, M asterclasses in Solid Dosage Forms, London, pp. 1 -1 4

Henrist, D,, Remon, J.P., 1999. Influence of the process parameters on the characteristics of starch based hot stage extrudates, Int. J, Pharm. 1 8 9 ,7 -1 7 ,

Hernandez-Trejo, N., Hinrichs WLJ, Visser, MR, Muller R.H., Kayser 0 , Frijtink E, (2005). Enhancement of the in vitro dissolution rate of the lipophilic drug buparvaquone by incorporation into solid dispersions, in: PharmSci. Fair. Nice, France,

Higuchi, W.I., Mir, N.A,, Desai, S.J., 1965. Dissolution rates of polyphase mixtures. J, Pharm, Sci, 54(10), 1405-1410.

Hilton J,E„ Summers, M.P,, 1986. The effect of wetting agents on the dissolution of indomethacin solid dispersion systems. Int. J. Pharm. 31 ,157 -164 .

Ho, H.O., Shu, H,L„ Tsai, T„ Sheu, M .T„ 1996, The preparation and characterization of solid dispersions on pellets using a fluidized bed system. Int. J, Pharm. 139, 223-229.

Ho, P,C„ Saville, D.J., Coville, P.F„ Wanwimolruk, S„ 2000. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products, Pharm, Acta Helv, 74. 379-3'85,

Hu, J„ Johnston, K.P., Williams, R.O, 3rd, 2004, Rapid dissolving high potency danazol powders produced by spray freezing into liquid process, Int. J, Pharm, 271(1-2), 145-54,

Huang, J,, Wigent, R,J,, Bentzley, C.M., Schwartz, J.B., 2006, Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery. Effect of drug loading on release kinetics. Int, J, Pharm. 319(1-2), 44- 54,

Huang, J„ Wigent, R.J„ Schwartz, J,B„ 2008, Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend, J. Pharm, Sci, 97(1), 251-62 .

Huettenrauch R„ 1974, Injection-molding technic for the production of oral delayed action preparations. 1. Injection molding. Pharmazie. 29 ,297 -302 .

Hughey, J.R., DiNunzio, J.C., Bennett, R.C„ Brough, C,, Miller, D.A., Ma, H., Williams, R.O. 3rd, McGinity, J.W., 2010, Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing. AAPS Pharm. Sci, Tech. 11(2), 760-74.

Hume-Rotherly, W., Raynor, G.V.. 1954. The Structure of Metals and Alloys, Institute of Metals, London, 3033-9,

Itai, S,, Nemoto, M,, Kouchiwa, S., Murayama, H., Nagai, T,, 1985. Influence of wetting factors on the dissolution behavior of flufenamic acid. Chem. Pharm. Bull. 33, 5464-5473,

C hap te r 7

344

Ito, A., Watanabe, T,, Yada, S., Hamaura, T,, Nakagami, H„ Higashi, K,, Moribe, K., Yamamoto, K„ 2010, Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NiVlR, int, J. Pharm, 383(1-2), 18-23,

Jaciiowicz R., 1987a, Dissolution rates of partially water-soluble drugs from solid dispersion systems, 1, Prednisolone. Int, J, Pharm, 35 ,1 -5 ,

Jachowicz, R., 1987b. Dissolution Rates of Partially Water-Soluble Drugs From Solid Dispersion Systems, II. Phenytoin, Int, J, Pharm, 35, 7-12,

Jachowicz, R,, Nuernberg, E,, 1997, Enhanced release of oxazepam from tablets containing solid dispersions, Int, J, Pharm. 159 ,149-158 ,

Jachowicz, R,, Nurnberg, E., Hoppe, R„ 1993, Solid dispersions of oxazepam, Int, J. Pharm. 99, 321-325,

Jafari, IV!,R,, Danti, A,G., Ahmed, I,, 1988. Comparison of polyethylene glycol, polyvinylpyrrolidone and urea as excipients for solid dispersion systems of miconazole nitrate. Int, J, Pharm, 48, 207-215,

Jain SK, Shukla M, Shrivastava V,, 2010, Development and in vitro evaluation of Ibuprofen mouth dissolving tablets using solid dispersion technique. Chem. Pharm, Bull, (Tokyo), 58(8), 1037-42,

Janssens, 8,, de Armas, H,N,, Roberts, C,J., Van den Mooter, G,, 2008, Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5, J, Pharm. Sci. 97(6), 2110 - 2120 ,

Janssens, S„ Denivelle, S., Rombaut, P., Van den Mooter, G., 2008. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends, Eur, J, Pharm. Sci, 35(3), 203-210.

Jensen, C .E„ dos Santos, R,A„ Denadai, A,M., Santos, C .F„ Braga, A,N,, Sinisterra, R.D,, 2010, Pharmaceutical composition of valsartan: beta-cyclodextrin: physico-chemical characterization and anti-hypertensive evaluation. Molecules. 15(6), 4067-84,

Joe, J,H„ Lee, W ,M „ Park, Y,J„ Joe, K,H„ Oh, D.H., Seo, Y.G ., Woo, J,S„ Yong, C ,S„ Choi, H,G,, 2010. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int. J, Pharm. 395(1-2). 161-6,

Kai, T,, Akiyama, V ,, Nomura, S., Sato, M ., 1996, Oral absorption improvement of poorly soluble drug using solid dispersion technique, Chem. Pharm, Bull, (Tokyo). 44(3), 568-71,

Kalaiselvan, R„ Mohanta, G,P„ Madhusudan, 8,, Manna, P.K., Manavalan, R„ 2007. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques, Pharmazie. 62(8), 604-607,

Kanagale, P., Patel, V., Venkatesan, N,, Jain, M., Patel, P., Misra, A„ 2008, Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine, Curr, Drug Deliv, 5(4), 306-11,

_____________________ __ ______________________________C h a p te r 7

3 4 5 ;

C h a p te r 7

Kanig J.L., 1964, Properties of fused mannitol in compressed tablets, J, Pharm, Sci. 53, 188- 192,

Karavas, E,, Georgarakis, E,, Sigalas, IV!.P,, Avgoustakis, K,, Bikiaris, D,, 2007b, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions, Eur, J, Pharm, Biopharm, 66(3), 334-347,

Karavas, E., Georgarakis, M,, Docoslis, A,, Bikiaris, D,, 2007a. Combining SEM , TEM . and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix, Int, J, Pharm. 340(1-2), 76-83,

Karavas, E,, Ktistis, G„ Xenakis, A., Georgarakis, E,, 2006c. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur, J. Pharm, Biopharm, 63(2), 103-114,

Karekar, P,, Vyas, V,, Shah, M,, Sancheti, P,, Pore, Y., 2009, Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. Pharm. Dev, Technol, 14(4), 373-9,

Kassem, A.A., Zaki, S.A., IVlursi, N.M., Tayel, S.A,, 1979, Chloramphenicol solid dispersion system I, Pharm, Ind. 41 ,390 -393 ,

Kaur, R,, Grant, D.J.W., Eaves, T., 1980. Comparison of poly-(ethylene glycol) and polyoxyethylene stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide II: Dissolution and solubility studies, J. Pharm. Sci, 69 ,1321 -1326 .

Kaushal, A.M., Gupta, P., Bansal, A.K., 2004. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit. Rev, Ther. Drug Carrier Syst. 21(3), 133-93,

Kearney, A.S., Gabriel, D.L., Mehta, S.C., Radebaugh, G.W ., 1994. Effect of polyvinylpyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory C I-987. Int. J, Pharm. 104 ,169-174 .

Kennedy, J, P., Niebergall, P.J., 1996. Development and optimization of a solid dispersion hot­bed fluid bed coating method. Pharm. Dev, Technol. 1, 51-62.

Kennedy. M,, Hu, J,, Gao, P., Li, L„ Ali-Reynolds, A., Chal, B., Gupta, V., Ma, C„ Mahajan, N„ Akrami, A„ Surapaneni, S., 2008, Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol Pharm, 5(6), 981-993.

Kerc, J., Srcic, 8,, 1995. Thermal analysis of glassy pharmaceuticals, Thermochim, Acta. 248, 81-95.

Khan, G.M., 2hu, J.B., 1998, Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG ), talc, and PEG-talc as dispersion carriers, Drug Dev. Ind. Pharm. 24, 455-462.

Khattab, I.S., Nada, A., Zaghloul, A.A., 2010. Physicochemical characterization of gliclazide- macrogol solid dispersion and tablets based on optimized dispersion, Drug Dev Ind Pharm. 36(8), 893-902,

346

Kim, E.J., Chun, M.K., Jang, J.S., Lee, I.H., Lee, K.R,, Choi, H.K., 2006. Preparation of a solid dispersion of felodipine using a solvent wetting method, Eur. J. Pharm. Biopharm. 64(2), 200- 205.

Kim, K.H., Jarowski, C.I., 1977, Surface tension lowering and dissolution rate of hydrocortisone from solid solutions of selected n-acyl esters of cholesterol. J. Pharm, Sci. 66 ,1 5 3 6 -1 5 4 0 .

Kissel, T., Li, Y., Unger, F„ 2002. ABA-tribiock copolymers from biode- gradable polyester A- blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins, Adv. Drug Del, Rev, 54, 99 -134 .

Kohri, N., Yamayoshi, Y,, Xin, H,, Iseki, K., Sato, N., Todo, S., Miyazaki, K., 1999, Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J. Pharm, Pharmacol, 51(2), 159- 64,

Kompella, U,B., Koushik, K., 2001. Preparation of drug delivery systems using supercritical fluid technology, Crit. Rev. Ther. Drug Carrier Syst, 18(2), 173-199.

Kondo, N., Iwao, T,, Hirai, K., Fukuda, M., Yamanouchi, K,, Yokoyama, K,, Miyaji, M., Ishihara, Y., Kon, K., Ogawa, Y,, et al, 1994. Improved Oral Absorption of Enteric Coprecipitates of a Poorly Soluble Drug. J. Pharm, Sci., 83(4), 566-570.

Kovarik, J.M,, Mueller, E.A., van Bree, J.B., Tetzloff, W ,, Kutz, K., 1994. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J. Pharm, Sci, 83(3), 444-446.

Kozjek, F„ Mrhar, A,, Bogataj, M„ Kobe, J„ 1988, The effect of physicochemicalproperties of acyclovirand deoxyaxyacy- clovir on the in vitro diffusion. Acta Pharm, Jugosl. 38, 61-69,

Kreuschner, K,, Fromming, K,H,, Hosemann, R,, 1980. Plug compounds - A new physical configuration of solid dispersions using the example of solidified phenylbutazone-urea melt embeddings, Acta Pharm. Tull, 26 ,159 -164 .

Kreuter, J„ 1999. Feste Dispersionen, in: J, Kreuter, C .D„ Herzfeldt (Eds.), Grundlagen der Arzneiformenlehre Galenik, 2, Springer, Frankfurt am Main, pp. 262-274,

Kristi, A,, Mrhar, A„ Kozjek, F„ Kobe, J„ 1989. Lipophilicity of guanine derivatives, int. J. Pharm, 57, 229-234.

Kubo, Y,, Terashima, Y„ Yagi, N., Nochi, H., Tamoto, K,, Seklkawa, H., 2009. Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol- polyvinylpyrrolidone in rabbits, Biol. Pharm, Bull. 32(11), 1880-4.

Kushida, I., Ichikawa, M.,. Asakawa, N„ 2002. Improvement of dissolution and oral absorption of ER-34122- a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti­inflammatory activity by preparing solid dispersion, J, Pharm, Sci. 91(1), 258-66.

Laitinen, R„ Suihko, E„ Bjorkqvist, M., Riikonen, J„ Lehto, V.P,, Jarvinen, K,, Ketolainen. J„ 2010, Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Dev Ind. Pharm. 36(5), 601-13.

Laitinen, R„ Suihko, E„ Toukola, K„ Bjorkqvist, M., Riikonen, J., Lehto, V .P ., Jarvinen, K.,

______________________________ Chap te r 7

3 47

Ketolainen, J„ 2009, Intraorally fast-dissolving particles of a poorly soluble drug; preparation and in vitro characterization, Eur, J. Pharm. Biopharm, 71(2), 271-81,

Langer. M., Holtje, M„ Urbanetz, N.A,, Brandt, B., Holtje, H,D„ Lippold, B.C., 2003, Investigations on the predictability of tlie formation of glassy solid solutions of drugs in sugar alcohols, Int, J, Pharm, 252(1- 2), 167-79,

Langer, M„ Urbanetz, N,A„ Lippold, B,C„ 2002. Supersaturation of carbamazepine released from glassy isomalt tablets. In: 4th World Meeting AD RITELF/APG I/APV, Florence,

Law, S,L., Lo, W .Y., Lin, F.M., Chang, C,H., 1992, Dissolution and absorption of nifedipine in poly(ethylene glycol) solid dispersion containing phosphatidylcholine, Int, J. Pharm. 84, 161- 166.

Lee J.C,, 1994. Hydroxypropyl methylcellulose phthalate, in: A, W ade, P.J. Weller (Eds,), Handbook of Pharmaceutical Excipients, American Pharmaceutical Association/The Pharmaceutical Press, Washington, DC/London, pp, 233-237,

Lefebvre, C., Brazier, M,, Robert, H„ Guyot-Hermann, A.M., 1985, Solid dispersions- why and how? Industrial aspect., S, T. P. Pharma. 1 ,300-322 .

Leonardi, D., Barrera, M,G,, Lamas, M.C., Salomon, G.J., 2007, Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters, AAPS Pharm, Sci, Tech, 8(4), E l 08,

Leonardi, D„ Salomon, C.J., 2010, Influence of water uptake, gel network, and disintegration time on prednisone release from encapsulated solid dispersions, Pharm. Dev, Technol. 15(2), 184-91,

Leuenberger, H„ 2002, Spray freeze-drying- the process of choice for low water soluble drugs? J. Nanoparticle Res, 4 ,111 -119 .

Leuner, C„ Dressman, J„ 2000, Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50 ,47 -60 ,

Levy, G., 1963, Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. Am. J. Pharm. 135 ,78-92 .

Lheritier, J., Ghauvet, A., Abramovici, B., Masse, J„ 1995, Improvement of the dissolution kinetics of SR 33557 by means of solid dispersions containing PEG 6000, Int. J, Pharm. 123, 273-279,

Li, D.X., Jang, K.Y., Kang, W „ Bae, K„ Lee, M ,H „ Oh, Y,K„ Jee, J,P„ Park, Y,J„ Oh, D .H „ Seo, Y,G„ Kim, Y.R., Kim, J ,0 ,, Woo, J,S„ Yong, C.S,, Choi, H.G,, 2010. Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium, Biol Pharm, Bull, 33(2), 279-284,

Li, J,, Guo, Y„ Zografi, G„ 2002. The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins, J. Pharm. Sci, 91(1), 229-43,

Li, L., AbuBaker, 0 . , Shao, Z.J„ 2006. Characterization of poly(ethylene oxide) as a drug

__ _____________ C h a p te r 7

348

C h a p te r 7

carrier in hot-melt extrusion. Drug Dev. Ind. Pharm, 32(8), 991-1002,

Lim, H.T., Balakrishnan, P., Oh, D.H., Joe, K.H., Kim, Y.R., Hwang, D.H., Lee, Y.B., Yong, C.S., Choi, H.G., 2010. Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. Int. J, Pharm, 397(1-2), 225-30.

Lin, C.W., Cham, T.M ., 1996. EITect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int. J. Pharm, 127 ,261 -272 .

Lin, D., Huang, Y., 2010. A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions. Int. J. Pharm. 399(1-2), 109-15,

Lipinski, C,A,, Lombardo, F„ Dominy, B.W,, Feeney, P.J., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev, 23, 3-25.

Liu, C„ Wu, J., Shi, B., Zhang, Y., Gao, T„ Pei, Y., 2006. Enhancing the bioavailability of cyclosporine a using solid dispersion containing poiyoxyethylene (40) stearate. Drug Dev. Ind. Pharm. 32(1), 115-123,

Liu, C., Zhu, S.J., Zhou, Y„ Wei, Y.P., Pei, Y.Y., 2006. Enhancement of dissolution of cyclosporine A using solid dispersions with poiyoxyethylene (40) stearate. Pharmazie. 61(8),681-684,

Liu, L,, Wang, X., 2007. Improved dissolution of oleanolic acid with ternary solid dispersions. AAPS Pharm.Sci. Tech .8 (4 ), E113.

Lloyd, G.R., Craig, D.Q., Smith, A., 1997. An investigation into the melting behavior of binary mixes and solid dispersions of paracetamol and PEG 4000, J, Pharm. Sci. 86(9), 991-996.

Lo, W .Y., Law, S.L., 1996, Dissolution behavior of griseofulvin solid dispersions using polyethylene glycol, talc, and their combination as dispersion carriers, Drug Dev. Ind. Pharm. 22,231-236.

Lobenberg, R., Amidon, G,L,, 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system, New scientific approaches to international regulatory standards. Eur. J. Pharm, Biopharm. 50(1), 3-12.

Lu, Q., Zografi, G., 1997. Properties of citric acid at the glass transition, J, Pharm. Sci. 86(12),1374-1378.

Ma, L,, Han, L , Zhang, Z„ Wang, J., 2009. Preparation and characterization of solid dispersions of ginkgolides. Zhongguo Zhong Yao Za Zhi. 34(11), 1368-72.

Maa, Y.F., Nguyen, P.A., Sweeney, T., Shire, S.J., Hsu, C.C., 1999. Protein inhalation powders; spray drying vs spray freeze drying, Pharm. Res, 16(2), 249-254,

Maa, Y.F., Zhao, L., Payne, L.G., Chen. D,, 2003. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application, J. Pharm. Sci. 92(2), 319-32,

Maes, P., Brusselmans, J., Sereno, A., Pitti, C,, Sonck, M,, Coffiner, M., 1996, In vitro and in

349

vivo behavior of some liquid or semisolid filled hard gelatin capsules. Bull. Technique Gattefosse, 89, 63-69.

Maghsoodi, M., Sadeghpoor, F., 2010. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Drug Dev. Ind. Pharm, 36(8), 917-925.

Margarit, M.V., Rodriguez, I.C., Cerezo, A., 1994. Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. Int. J. Pharm. 108, 101-107.

Marsac, P.J., Rumondor, A.C., Nivens, D.E., Kestur, U.S,, Stanciu, L,, Taylor, L.S., 2010. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J. Pharm. Sci, 99(1):169-185.

Martin-Facklam, M., Burhenne, J., Ding, R., Fncker, R., Mikus, G., W alter-Sack, I., Haefeli, W.E., 2002. Dose-dependent increase of saquinavir bioavaiiabiiity by the pharmaceutic aid cremophor EL. Or, J, Clin. Pharmacol. 53(6), 576 -581 .

!\^atsumoto, T., Zografi, G., 1999. Physical properties of solid molecular dispersions of indomethacin with poiy(vinylpyrrolidone) and poly (vinylpyrrolidone-co-vinyi-acetate) in relation to indomethacin crystallization, Pharm, Res, 1 6 ,1 7 2 2 -1 7 2 8 .

Matsunaga, N,, Nakamura, K„ Yamamoto, A., Taguchi, E,, Tsunoda, H,, Takahashi, K., 2006. Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEG F receptor-2 tyrosine kinase, and identification of its potential therapeutic window. Mol. Cancer Ther, 5(1), 80-88,

Maurya, D„ Belgamwar, V., Tekade, A, 2010. Microwave Induced solubility enhancement of poorly water soluble atorvastatin calcium, J, Pharm. Pharmacol. 62(11), 1599-1606.

Mayersohn, M,, Gibaldi, M., 1966. New method of solid-state dispersion for Increasing dissolution rates, J. Pharm. Sci. 55 ,1323-1324 .

McGinity, J.W., Maincent, P., Steinfink, H., 1984. Crystalllnity and dissolution rate of tolbutamide solid dispersions prepared by the melt method, J, Pharm. Sci. 73(10), 1441-4,

Mehanna, M.M., Motawaa, A.M., Samaha, M.W., 2010. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement. Int. J. Pharm. [Epub ahead of print].

Mehramizi, A„ Aiijanl, B„ Pourfarzib, M„ Dorkoosh, F.A., Rafiee -TehranI, M,, 2007. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system. Drug Dev. Ind. Pharm. 33(8), 812-823,

MEMP-03G730e-04 June, 2007, Soluble Kollldon® grades, BASF. p. 1-16,

Mesnukul, A,, Yodkhum, K„ Phaechamud, T,, 2009, Solid Dispersion Matrix Tablet Comprising Indomethacin-PEG-HPMC Fabricated with Fusion and Mold Technique, Indian J, Pharm, Sci, 71(4), 413-20.

_________________________________ C h a p te r 7

3 5 0

Mineo, H„ Hara, H., Shigematsu, N., Okuhara, Y„ Tomita, F., 2002. Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro, J, Nutr. 132(11), 3394- 3399,

Mirza, S,, Heinan)aki, J„ Miroshnyk, I,, Rantanen, J., Christiansen, L , Karjalainen, M., Yliruusi, J., 2006, Understanding processing-induced phase transformations in erythronnycin-PEG 6000 solid dispersions, J. Pharm, Sci, 95(8), 1723-1732.

Mishra, D.N., Vijaya Kumar, S.G„ 2006, Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk, Yakugaku Zasshi, 126(7), 495-498,

C h a p te r 7

Ji, A,, Tayade, P,, 2006, Enhancement of dissolution profile by solid dispersion (kneading) technique, AAPS Pharm. Sci. Tech. 7(3), 68,

Mohammadi, G„ Barzegar-Jalali, M,, Valizadeh, H„ Nazemiyeh, H,, Barzegar-Jalali, A., Siahi Shadbad, M.R., Adibkia, K,, Zare, M„ 2010, Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone. J, Pharm, Pharm, Sci. 13(2), 152-61,

Mollmann, S.H., Bukrinsky, J.T., Elofsson, U,, Elversson, J,, Frokjaer, S., Thalberg, K„ Millqvist-Fureby, A.. 2006, The stability of insulin in solid formulations containing meiezitose and starch. Effects of processing and excipients. Drug Dev. Ind. Pharm, 32(6), 765-778,

Moneghini, M., Carcano, A„ Zingone, G., Perissutti, B., 1998, Studies in dissolution enhancement of atenolol, Int, J, Pharm. 175 ,177-183 ,

Moneghini, M,, Kikic, I,, Voinovich, D., Perissutti, B., Filipovic-Grcic, J, 2001, Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. Int. J, Pharm. 222(1), 129-38,

IVIoriyama, M., Inoue, A„ Isoya, M„ Tanaka, M„ Hanano, M., 1978. Dissolution properties and gastrointestinal absorption of chioramphenicol from hydrophilic high molecular compound coprecipitates. Yakugaku Zasshi. 98(8), 1012-8,

Morris, K.R., Knipp, G.T., Serajuddin, A.T.M., 1992. Structural properties of poly(ethylene glycol)-polysorbate 80 mixture, a solid dispersion vehicle. J. Pharm. Sci, 8 1 ,1 1 8 5 -1 1 8 8 .

Mosharraf, M,, Sebhatu, T„ and Nystrom, C., The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs, Int, J, Pharm., 1999.177(1): p, 29-51,

Mullins, J,D,, Macek, T,J,, 1960, Some pharmaceutical properties of novobiocin, J, Am. Pharm, Assoc, Sci, Ed, 49, 245-248,

Mura, P„ Faucci, M .T,, Manderioli, A„ Bramanti, G„ Parrini, P., 1999. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions, Drug Dev, Ind. Pharm. 25, 257-264,

Mura, P,, Manderioli, A,, Bramanti, G., Ceccarelli, L,, 1996. Properties of solid dispersion of naproxen in various poly(ethylene glycol)s. Drug Dev, Ind. Pharm, 22, 909-916.

351

Najib, N.M., Salem, M.A.S., 1987. Release of ibuprofen from polyethylene glycol solid dispersions: Equilibrium solubility approach. Drug Del, Ind. Pharm. 13, 2263-2275.

Nakamichi, K„ Yasuura, H„ Kukui, H., Oka, M., Izumi, S., Andou, T., Shimizu, N., Ushimaru, K., 1996, New preparation method of solid dispersion by twin srew extruder, Pharm, Tech, Jpn. 12 ,715 -72 9 ,

Nakamichi, K,, Yasuura, H,, Shougo, I,, 1991, Method of manufacturing solid dispersion, Eur, Patent 0,580,860,

Ndindayino, F,, Vervaet, C,, Van den Mooter, G,, Remonv, J,P,, 2002, Direct compression and moulding properties of co-extruded isomalt/drug mixtures, Int. J. Pharm, 235, 159-168,

Nelson, E,, 1957, Solution rate of theophylline salts and effects from oral administration, J, Am. Pharm. Assoc, Sci, Ed, 46, 607-614,

Nepal, P.R., Han, H.K., Choi, H.K.. 2010, Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation, Int, J, Pharm, 383(1-2), 147-53.

Nernst, W,, 1904, Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Zeitschrift f, Physik. Chem, 47, 52-102.

Neumann, J., Breitenbach, J., Schrof, W., 1999, Confocal Raman spectroscopy: analytical approach to solid dispersions and mapping of drugs, Pharm, Res. 1 6 ,1 1 0 9 -1 1 1 3 ,

Newa, M„ Bhandari, K,H„ Kim, J.O., Im, J,S„ Kim, J.A., Yoo, B,K„ Woo, J,S„ Choi, H.G„ Yong, C.S., 2008. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems. Chem. Pharm, Bull, (Tokyo), 56(4), 569-574.

Newa, M,, Bhandari, K.H,, Lee, D,X,, Sung, J.H., Kim, J.A., Yoo, B.K., Woo, J,S„ Choi, H,G„ Yong, C,S,, 2008, Enhanced dissolution of ibuprofen using solid dispersion with polyethylene glycol 20000. Drug Dev. Ind. Pharm. 34(10), 1013-1021,

Newa, M., Bhandari, K.H., Oh, D.H., Kim, Y.R., Sung, J.H., Kim, J.O, Woo, J.S., Choi, H.G., Yong, C.S., 2008. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arch. Pharm. Res. 31(11), 1497-1507.

Norvir capsules, Physician's Desk Reference 1997; Medical Economics Company: Montvale, NJ.

Note for guidance on impurities: residual solvents (C PM P/IC H /283/95), 1998, in: The European Agency for the Evaluation of Medicinal Products, EMEA: London, p, 1-18,

Noyes, A,A„ Whitney, W .R., 1987, The rate of solution of solid substances in their own solutions, J. Am, Chem. Soc. 19 ,930-934.

Oh, D.H„ Park, Y,J,, Kang, J.H., Yong, C .S., Choi, H.G., 2010, Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv, [Epub ahead of publication],

Okimoto, K., Miyake, M., Ibuki, R., Yasumura, M ., Ohnishi, N., Nakai, T., 1997, Dissolution mechanism and rate of solid dispersion particles of nilvadipine with

________________ __________ ___ __________________ C h a p te r 7

352

C h a p te r 7

hydroxypropylmethylcellulose, Int, J. Pharm. 159 ,85 -93 .

Okonogi, S., Oguchi, T., Yonemochi, E., Puttipipatkhachorn, S,, Yamamoto, K., 1997a, Improved dissolution of ofloxacin via solid dispersion. Int. J. Pharm. 156 ,175 -180 .

Okonogi, S,, Puttipipatkhachorn, S., 2006, Dissolution improvement of high drug-loaded solid dispersion, AAPS Pharm, Sci, Tech. 7(2), E52,

Okonogi, S., Yonemochi, E., Oguchi, T,, Puttipipatkhachorn, S., Yamamoto, K., 1997b. Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Dev. Ind. Pharm. 23, 1115-1121.

Onoue, S., Aoki, Y., Kavi/abata, Y., Matsui, T., Yamamoto, K,, Sato, H., Yamauchi, V., Yamada, S., 2010. Development of inhalable nanocrystalline solid dispersion of Tranilast for airway inflammatory diseases, J, Pharm, Sci. [Epub ahead of publication].

Onoue, S„ Sato, H., Ogawa, K., Kawabata, Y., Mizumoto, T,, Yuminoki, K., Hashimoto, N., Yamada, S„ 2010, Improved dissolution and pharmacokinetic behavior of cydosporine A using high-energy amorphous solid dispersion approach. Int, J, Pharm. 399(1-2), 94-101.

Orienti, I., Bigucci, F, Luppi, B., Cerchiara, T., Zuccari, G,, Giunchedi, P., Zecchi, V ., 2002. Polyvinylalcohol substituted with triethyleneglycolmonoethylether as a new material for preparation of solid dispersions of hydrophobic drugs. Eur, J. Pharm. Biopharm. 54(2), 229-33,

Oshima. T,, Sonoda, R„ Ohkuma, M,, Sunada, H., 2007, Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions. Chem. Pharm. Bull. (Tokyo). 55(11), 1557- 1562.

Overhoff, K.A., Moreno, A,, Miller, D.A., Johnston, K.P., Williams, R.O. 3rd., 2007. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing, Int, J. Pharm. 336(1), 122-132.

Owusu-Ababio, G., Ebube, N.K., Reams, R,, Habib, M., 1998, Comparative dissolution studies for mefenamic acid-poly-(ethylene glycol) solid dispersion systems and tablets, Pharm, Dev. Technol, 3, 405-412.

Padhi, B,K,, Chouguie, M,B„ Misra, A,, 2009. Aerosol performance of targe respirable particles of amikacin sulfate produced by spray and freeze drying techniques, Curr. Drug Deliv. 6(1), 8- 16.

Palakodaty, S., York, P., 1999. Phase behavioral effects on particle formation processes using supercritical fluids. Pharm. Res., 16(7), 976-85.

Palanisamy, iVl„ Khanam, J., 2010, Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile, Drug Dev, Ind. Pharm, [Epub ahead of print],

Paradkar, A„ Ambike, A.A., Jadhav, B.K„ Mahadik, K.R., 2004. Characterization of curcumin- PVP solid dispersion obtained by spray drying. Int, J, Pharm, 271(1-2), 281-6.

Park, M.J„ Ren, S., Lee, B,J,, 2007, In vitro and in vivo comparative study of itraconazole bioavaiiability when formulated in highly soluble self-emulsifying system and in solid dispersion.

353

C h a p te r 7

Biopharm, Drug Dispos. 28(4), 199-207.

Park, Y.J,, Lee, H.K., Im, Y.B., Lee, W., Han, H,K,, 2010. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion, Arch Pharm Res, 33(8), 1235-40,

Park, Y.J., Ryu, D.S„ Li, D.X., Quan, Q.Z., Oh, D.H., Kim, J.O., Seo, Y .G ., Lee, Y ,l„ Yong, C,S„ Woo, J,S„ Choi, H.G., 2009. Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate, Arch, Pharm. Res, 32(6), 893-898,

Park, Y,J.. Xuan, J,J,, Oh, D.H., Balakrishnan, P., Yang, H.J., Yeo, W .H ., Lee, M,K„ Choi, H.G., Yong, C.S., 2010. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability. Arch. Pharm. Res, 33(8), 1217-25.

Parks, G,S,, Snyder, L.J., Cattoir, F,R,, 1934, Studies on glass. XI. Some thermodynamic relations of glassy and alfa-crystalline glucose. J. Chem. Phys. 2, 595-598.

Patel, R.P., Patel, M.M., 2007. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30, Pharm, Dev, Technol, 12(1), 21-33,

Patel, A,R,, Joshi, V.Y., 2008. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. AAPS Pharm. Sci. Tech. 9(2), 583-90.

Pathak, D,, Dahiya, S., Pathak, K., 2008. Solid dispersion of meloxicam: factoriaily designed dosage form for geriatric population. Acta. Pharm. 58(1), 99-110.

Perissutti, B., Newton, J., John, M., Podczeck, F., Rubessa, P., 2002. Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. Eur. J, Pharm. Biopharm. 5 3 ,1 2 5 -1 3 2 .

Perng, C.Y., Kearney, A,S., Patel, K., Palepu, N.R., Zuber, G., 1998. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly w ater soluble 5‘ lipoxygenase inhibitor. Int. J. Pharm. 176, 31-38.

Pikal, M,J„ Lukes, A.L., Lang, J,E„ Gaines, K., 1978. Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. J. Pharm. Sci. 67(6), 767-773.

Plasticizers and drugs on the physical-mechanical properties of hydroxypropylceliulose films prepared by hot-melt extrusion, Drug Dev, Ind. Pharm. 25 (1999) 625 -633 ,

Portero, A„ Remunanlopez, C., Vilajato, J,L._, 1998. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J, Pharm. 175, 75-84.

Pouton, C,W,, 1997. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25 .47 -58 ,

Pouton, C.W., 2000. Lipid formulations for oral administration of drugs: non- emulsifying, self- emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J, Pharm. Sci,, 11 (Suppl 2),

354

C h a p te r 7

S93-8.

Pozzi, F., Longo, A,, Lazzarini, C„ Carenzi, A „ 1991. Formulations of ubidecarenone with improved bioavailability, Eur, J. Pharm. Biopharm, 37, 243-246,

Price, J,C., 1994, Polyethylene glycol, in: A. W ade, P,J. Weller (Eds,), 1994, Handbook of Pharmaceutical Excipients, American Pharmaceutical Association/The Pharmaceutical Press, Washington, DC/London, pp, 355-361.

R, LoBrutto, R,, Makarov, A,, Jerkovich, A,, McGill, R., Kazakevich, Y,, Vivilecchia, R„ 2008, Enhancing productivity in the analytical laboratory through the use of ultra fast HPLC in preformulation/formulation development. J, Liq. Chromatogr, Relat, Technol, 31, 225 3 -2 285 ,

Radiilescu F,, Miron, D,, Mircioiu, C., Voicu V,A,, 2007. Distribiilion profiles of drugs with active metabolites by cotnpartmental analysis, Farmacia, 4, 390-395.

Rahamathulla, M„ Hv, G,, Rathod, N,, 2008, Solubility and dissolution improvement of Rofecoxib using solid dispersion technique. Pak. J, Pharm, Sci, 21(4), 350-355.

Rahman, Z,, Zidan, A,S,, Khan, M,A,, 2010, Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods, AAPS J, Pharm. Sci, Tech, 12(2), 158-170,

Rahman, Z„ Zidan, A.S,, Khan, M,A„ 2010, Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. Int. J. Pharm, 400(1-2), 49-58,

Rajebahadur, M., Zia, H„ Nues, A., Lee, C., 2006. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol H S -15. Drug Deliv. 13(3), 201 -206.

Ramadan, E,M,, Abd El-Gawad, A.H., Nouh, A.T., 1987. Bioavailabiiity and erosive activity of solid dispersions of some non-steroidal anti-inflammatory drugs, Pharm, Ind. 49, 508-513.

Rane, Y,, Mashru, R,, Sankalia, M,, Sankalia, J., 2007, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology, AAPS Pharm, Sci, Tech, 8(2), Article 27.

Rasenack, N., Hartenhauer, H., Muller, B .W „ 2003. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J, Pharm. 254 ,13 7 -1 45 .

Rastogi, R,P„ Rama Varma, K,T„ 1956. Solid-liquid equilibria in solutions of non-electrolytes, J, Ghem, Soc, 2, 2097-2101,

Reed-Hill, R.E,, 1964. Physical Metallurgy Principles, Van-Nostrand, Princetown, NJ.

Ren, F,, Jing, Q„ Tang, Y., Shen, Y,, Chen, J„ Gao, F„ Cui, J., 2006, Characteristics of bicalutamide solid dispersions and improvement of the dissolution. Drug Dev. Ind, Pharm, 32(8), 967-972,

Repka, M,A,, Gerding, T.G., Repka, S,L„ McGinity, J.W „ 1999. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropyiceliulose films prepared by hot- melt extrusion. Drug Dev, Ind, Pharm, 25, 625 -63 3 ,

355

Rettig, H„ Mysicka, J„ 2008. iViVC: Methods and Applications in Modified-Release Product Development. Dissolution technologies, Feb, 6-8.

Rogers, J. A., Anderson, A.J., 1982, Physical characteristics and dissolution profile of ketoprofen-urea solid dispersions. Pharm Acta Helv, 57 ,276 -281 .

Rogers, T,L„ Nelsen, A.C., Hu, J., Brown, J.N., Sarkari, M., Young, T.J.. Johnston, K.P., Williams, R.O, 3rd., 2002. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur. J. Pharm. Biopharm. 54(3), 271-280

Roth, W,, Setnik, B., Zietsch, M., Burst, A., Breitenbach, J., Sellers, E., Brennan, D., 2009. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation. Int. J. Pharm. 368(1-2), 72-75.

Rothen-Weinhold, A., Besseghir, K., Vuaridel, E„ Sublet, E., Oudry, N., Kubel, F., Gurny, R.,1999. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants. Eur. J, Pharm. Biopharm. 4 8 ,1 1 3 -1 2 1 .

Rumondor, A.C., Ivanisevic, I., Bates, S., Alonzo, D.E., Taylor, L.S., 2009 Evaluation of drug- polymer miscibility in amorphous solid dispersion systems, Pharm. Res. 26(11), 2523-2534.

Rumondor, A.C., Marsac, P.J., Stanford, L.A., Taylor, L.S., 2009. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol, Pharm. 6(5), 1492-1505.

Rumondor, A.C., Stanford, L.A., Taylor, L.S., 2009. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm, Res. 26(12), 2599-606.

Saerens, L , Dierickx, L„ Lenain, B., Vervaet, C„ Remon, J,P„ Beer TD ., 2010, Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process, Eur, J. Pharm. Biopharm. [Epub ahead of print],

Saers, E,S„ Nystrom, C., Alden, M„ 1993, Physicochemical aspects of drug release, XVI, The effect of storage on drug dissolution from solid dispersions and the influence of cooling rate and incorporation of surfactant, int, J, Pharm. 9 0 ,105 -11 8 ,

Sahoo, J,, Murthy, P.N., Biswal, S„ iVlanik,, 2009, Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. AAPS Pharm, Sci, Tech, 10(1), 27-33,

Sammour, O.A., Hammed, M,A., Megrab, N,A,, Zidan, A,S., 2006. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion, AAPS Pharm, Sci, Tech, 7(2), E55,

Sancheti, P.P., Vyas, V,M ,, Shah, M„ Karekar, P,, Pore, Y.V,, 2008, Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems. Pharmazie, 63(8), 571-575.

Sangalli, M,E., Maroni, A„ Zema, L,, Busetti, C„ Giordano, F„ Gazzaniga, A,, 2001, In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Contr Rel. 73,103-110.

C h a p te r 7

356

Sarkari, M„ Brown, J„ Chen, X„ Swinnea, S., Williams, R.O. 3rd, Johnston, K.P., 2002. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 243(1-2), 17-31.

Save, T,, Venkitachalam, P., 1992. Studies on solid dispersions of nifedipine, Drug Dev. Ind. Pharm. 18(15), 1663-1679,

Sohenkel, F., Rudaz, S., Daali Y., Oestreicher M.K,, Veuthey, J.L., Dayer, P., 2005. Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor. J. Chromatogr, B Analyt. Technol. Biomed. Life Sci. 826(1-2), 1-7,

Schwarz, G,, 1978, Estimating the dimension of a model. Ann. Slat, 6 ,4 6 1 -4 6 4 .

Sebhatu, T,, Angberg, M,, Ahlneck, C„ 1994. Assesment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int. J, Pharm, 104 ,135-144.

Sekiguchi, K,, Obi, N., 1961. Studies on Absorption of Eutectic Mixture, I, A comparison of the behaviour of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Cham, Pharm, Bull. 9, 866-872.

Sekiguchi, K., Obi, N., Ueda, Y,, 1964. Studies on absorption of eutectic mixtures, !l, Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem. Pharm, Bull. 12,134-144,

Sekikawa, H,, Fujiwara, J., Naganuma, T,, Nakano, M., Arila, T., 1978b. Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitale, Chern. Pharm. Bull. (Tokyo), 26(10), 3033-3039,

Sekikawa, H., Fukuda, W ., Takada, M., Ohtani, K., Arita, T., Nakano, N., 1983. Dissolution behavior and gastrointestinal absorption of dicumaro! from solid dispersion systems of dicumarol-polyvinylpyrrolidone and dicumarol- beta-cyclodextrin, Chem, Pharm, Bull. (Tokyo). 31(4), 1350-1356

Sekikawa, H„ Nakano, M., Arita, T., 1978a. Dissolution behaviors and gastrointestinal absorption of sulfisoxazole in sulfisoxazole-polyvinylpyrrolidone coprecipilale. Yakugaku Zasshi. 98(1), 62-6.

Sekikawa, H„ Nakano, M,, Arila, T„ 1979. Dissolulion mechanisms of drug-polyvinylpyrrolidone Goprecipitates in aqueous solution, Chem, Pharm. Bull. (Tokyo). 27(5), 1223-30,

Sekikawa, H„ Nakanoa, M„ Arila, T„ 1978. Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem. Pharm. Bull, 26 ,118 -26 .

Serajuddin, A.T., 1999. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm, Sci, 88(10), 1058-66,

Serajuddin, A,T,, Sheen, P,C„ Augustine, M.A., 1990b, Improved dissolution of a poorly water- soluble drug from solid dispersions in polyethylene glycol; polysorbate 80 mixtures. J, Pharm, Sci. 79(5), 463-464,

Serajuddin, A.T,M„ 1997, Bioavailability enhancement of poorly water-soluble drugs by solid

_______ _____________ _____________________________ __________ ___________ C h ap ter 7

3 5 7

dispersion in surface active and self-emulsifying vehicles. Bull, Technique Gattefosse, 90, 43- 50.

Serajuddin, A.T.M,, Sheen, P.C., Augustine, M.A., 1986. W ater migration from soft gelatin capsule shell to fill material and its effect on drug solubility, J, Pharm, Sci, 75, 62-64,

Serajuddin, A,T,1VI,, Sheen, P.C., Augustine, M.A., 1990, improved dissolution of a poorly water-soluble drug from solid dispersions in poly(ethylene glycol):polysorbate 80 mixtures. J, Pharm. Sci. 79, 463-464.

Serajuddin, A.T.M., Sheen, P.C., Mufson, D., Bernstein, D.F., Augustine, M,A., 1988a, Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J. Pharm. Sci. 77, 414-417,

Serajuddin, A,T.M,, Sheen, P.C., iVlufson, D., Bernstein, D.F., Augustine, M.A., 1988b. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. J, Pharm. Sci. 77, 325-329.

Sertsou, G., Butler, J., Scott, A., Hempenstall, J., Rades, T„ 2002. Factors affecting incorporation of drug into solid solution with HPM CP during solvent change co-precipitation. Int. J, Pharm. 245(1-2), 99-108.

Sethia, S., Squillante, E., 2002. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J. Pharm. Sci. 91(9), 1948-57,

Sethia, S,, Squillante, E., 2003, Solid dispersions: revival with greater possibilities and applications in oral drug delivery, Crit. Rev. Ther. Drug Carrier Syst. 20(2-3), 215-47.

Shah, H.J., Subbaiah, G ., Patel, D.M., Patel, C ,N„ 2009, In vitro-in vivo correlation of modified release dosage form of lamotrigine, Biopharm, Drug Dispos, 30(9), 524-531.

Shah, J.C., Chen, J.R., Chow, D., 1995. Preformulation study of etoposide. 2. Increased solubility and dissolution rate by solid-solid dispersions, Int. J. Pharm. 113 ,10 3 -1 11 .

Shah, N, H„ Phuapradit, W „ Ahmed, H„ 1996, Liquid/semlsolid filling in hard gelatin capsules: Formulation and processing considerations. Bull, Technique Gattefosse. 89, 27-37.

Shah, P.P., Mashru, R ,C„ 2008, Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. AAPS Pharm. Sci. Tech. 9(2), 494-500.

Shah, T.J., Amin, A,F,, Parikh, J,R„ Parikh, R ,H„ 2007, Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug, AAPS Pharm. Sci. Tech. 8(2), Article 29.

Shanbhag, A;, Rabel, S., Nauka, E., Casadevall, G., Shivanand, P., Eichenbaum, G., Mansky, P,, 2008, Method for screening of solid dispersion formulations of low-soiubility com pounds- miniaturization and automation of solvent casting and dissolution testing, Int, J. Pharm. 351(1- 2), 209-218,

Shanmugam, S„ Park, J.H., Sang-Cheol, C,, Yong, C.S., Choi, H.G ., W oo, J,S. 2010,

___ ________________ ____________________________________________ ___ C h a p te r 7

; “ ̂ ~ 3 5 8

Antitumor Efficacy of Solid Dispersion of Paclitaxel Prepared by Supercritical Antisolvent Process in Human Mammary Tumor Xenografts, Int. J, Pharm. [Epub ahead of print],

Shaw, D.J,, 1992, Surface and interfacial tensions, in introduction to Colloid & Surface Chemistry, Butterworth-Heinemann, Oxford, p, 67-69,

Sheehan, C„ Auxiliary Information-Expert Committee: (EG C05) Excipient General Chapters USP29-N F24, Pharmacopeia! Forum, 28(2), 618,

Sheen, P,C„ Khetarpal, V.K„ Gariola, G.IVI,, Rowlings, C ,E„ 1995. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm, 18, 221- 227.

Sheen, P.C., Kim, S.l,, Petillo, J,J„ Serajuddln, A,T,M ., 1991, Bioavailability of a poorly water- soluble drug from tablet and solid dispersion in humans. J. Pharm, Sci, 80, 7'!2-714.

Shen, S.C., Ng, W .K., Chia, L., Dong, Y.C., Tan, R.B., 2010 Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. J. Pharm. Sci. 99(4), 1997-2007.

Sheu, M.T., Yeh, C.M ,, Sokoloski, T.D., 1994, Characterization and dissolution of fenoflbrate solid dispersion systems. Int. J, Pharm. 103, 137-146.

Shibata, Y,, Fujii, M,, Kokudai, M,, Noda, S., Okada, H., Kondoh, M., W atanabe, Y„ 2007. Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone. J, Pharm. Sci, 96(6), 1537-1547.

Shibata, Y,, Fujii, M,, Noda, S,, Kokudai, M., Okada, H., Kondoh, M., W atanabe, Y., 2006. Fluidity and tableting characteristics of a powder solid dispersion of the low melting drugs ketoprofen and ibuprofen with crospovidone. Drug Dev, Ind, Pharm. 32(4), 449-456.

Shibata, Y„ Fujii, IV!., Sugamura, Y,, Yoshikawa, R., Fujimoto, S., Nakanishi, S., Motosugi, Y., Koizumi, N., Yamada, M., Ouchi, K., Watanabe, Y., 2009. The preparation of a solid dispersion powder of Indomethacin with crospovidone using a twin-screw extruder or kneader. int. J. Pharm. 365(1-2), 53-60.

Shimpi, S,L,, iVlahadlk, K,R„ Paradkar, A.R., 2009. Study on mechanism for amorphous drug stabilization using gelucire 50/13. Chem. Pharm. Bull. (Tokyo). 57(9), 937-42.

Shin, S., Oh, l„ Lee, Y., Choi, H., Choi, J., 1998. Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone. Int. J. Pharm. 1 7 5 ,17-24.

Shinde, V.R., Shelake. M ,R„ Shetty, S,S„ Chavan-Patil, A,B„ Pore, Y.V., Late, S.G ., 2008. Enhanced solubility and dissolution rate of lamotrigine by inclusion compiexation and solid dispersion technique, J. Pharm. Pharmacol. 60(9), 1121-1129,

Shrivastava, A.R., Ursekar, B., Kapadia, C.J,, 2009, Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets, Curr, Drug Dellv. 6(1), 28-37,

Silva, T,D„ Arantes, V ,T„ Resende, J,A., Spezlali, N.L„ de Oliveira, R,B„ Vianna-Soares, C.D., Preparation and characterization of solid dispersion of simvastatin. Drug Dev. Ind. Pharm,

Cha p te r 7

359

C hapter 7

36(11):1348-55,

Simonelli, A,P., Mehta, S,C,, Higuchi, W .I., 1969. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates, J, Pharm. Sci, 58(5), 538-49,

Simonelli, A,P,, Mehta, S.C., Higuchi, W ,l., 1976, Dissolution rates of high energy sulfathlazole' povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies, J, Pharm, Sci, 65. 355-361,

Singh, P., Guillory, J,K,, Sol<oloski, T,D,, Benet, L,Z., Bhatia, V,N., 1966, Effect of inert tablet ingredients on drug absorption. I, Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. J. Pharm. Sci. 55(1), 63-8,

Singia, A,K„ Vijan, T,, 1990, Dissolution of sulfamethoxazole from polyethylene glycols and polyvinyl pyrrolidone solid dispersions. Drug Dev. Ind. Pharm. 16 ,875 -82 .

Sivert, A., Berard, V., Andres, C., 2010. New binary solid dispersion of indonnethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement. J, Pharm. Sci. 99(3), 1399-1413.

Six, K,, Verreck, G., Peeters, J., Brewster, M., Van Den Mooter, G., 2004. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by soliddispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93(1), 124-31.

Sjoekvist, E., Nystroem, C., Aldean, M., Caram-Lelham, N„ 1992. Physicochemical aspects ofdrug release, XIV, The effects of some ionic and non-ionic surfactants on properties of asparingly soluble drug in solid dispersions. Int, J. Pharm. 79 ,123 -133 ,

Sjokvist, E., Nyslrom, C., 1988. Physicochemical aspects of drug release. V I. Drug dissolution rate from solid particulate dispersions and the importance of carrier and dry particle properties. Int, J, Pharm. 47, 51-66,

Sparreboom, A., van Teliingen, 0 . , Nooijen, W ,J„ Beijnen, J.H., 1996. Nonlinearpharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res. 56, 2112-2115.

Speiser, P„ 1966, Galenic aspects of the drugs. Pharm, Acta Helv. 41, 321-342.

Srinarong, P,, Faber, J.H,, Visser, M.R., Hinrichs, W .L., Frijlink, H.W ., 2009. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants, EurJ Pharm Biopharm. 73(1 ):154-161

Srinarong, P., Kouwen, S., Visser, M.R., Hinrichs, W .L , Frijlink, H.W ,, 2010. Effect of drug- carrier interaction on the dissolution behavior of solid dispersion tablets. Pharm Dev Technol. 15(5), 460-8,

Staniforth, J.N., Aulton, M.E., 2007. Powder Flow, in: Aulton's Pharmaceutics. The Design of Medicines, M.E. Aulton, (Ed.), 3rd Edn. Harcourt Publishers ltd. Philadelphia USA. pp: 169- 179,

Stenberg, P., Luthman, K„ Ellens, H., Lee, C.P., Smith, P .L , Lago, A., Elliott, J.D., Artursson, P„ 1999, Prediction of the intestinal absorption of endothelin receptor antagonists using three

360

C h a p te r 7

theoretical methods of increasing complexity, Ptiarm, Res. 1999 ,16 (10 ), 1520-6.

Stoll R.T., Bates, T.R ., Nieforth, K,A„ Swarbrick, J., 1969. Some physical factors affecting the enhanced blepharototic activity of oraily administered reserpine-cholanic acid coprecipitates. J. Pharm, Sci. 58, 1457-1459.

Stupal<, E.J., Bates, T.R,, 1973, Enhanced absorption of digitoxin from orally administered digitoxin-polyvinylpyrrolidone coprecipitates, J. Pharm, Sci, 62(11), 1806-9,

Subramaniam, B,, Rajewsl<i, R.A., Snavely, K,, 1997. Pharmaceutical processing with supercritical carbon dioxide, J. Pharm. Sci. 86(8), 885-90,

Suhagia, B.N., Patel, H.M., Shah, S.A., Rathod, I., Parmar, V.K., 2006. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions. Acta. Pharm. 56(3), 285-298,

Summers, M.P., Enever, R.P., 1976. Preparation and properties of solid dispersion system containing citric acid and primidone. J. Pharm. Sci. 65(11), 1613-1617.

Sun, Y,, Rui, Y., Wenliang, Z,, Tang, X., 2008. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int. J. Pharm. 359(1-2), 144-149.

Suzuki, H., Miyamoto, N,, Masada, T,, Hayakawa, E., Ito, K,, 1996, Solid dispersions of benidipine hydrochloride. 1. Preparations using different solvent systems and dissolution properties. Chem, Pharm. Bull. 44, 364-371.

Suzuki, H., Sunada, H., 1997. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems, Chem. Pharm. Bull. 45 ,1 6 8 8 -1 6 9 3 ,

Tachibana, T., Nakamura, A„ 1965. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: dispersion of beta-carotene bypolyvinylpyrrolidone, Kolloid-Z, Polym. 203 ,13 0 -1 33 ,

Tanaka, N„ Imai, K., Okimoto, K„ Ueda, S„ Tokunaga, Y,, Ibuki, R„ Higaki, K„ Kimura, T., 2006. Development of novel sustained-release system, disintegration-controlled matrix tablet (DGMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. J, Contr. Rel. 112(1), 51-56.

Tantishaiyakul, V., Kaewnopparat, N,, Ingkatawornwong, S „ 1996. Properties of soliddispersions of piroxioam in polyvinylpyrrolidone K-30, Int. J. Pharm. 143, 59-66.

Tantishaiyakul, V,, Kaewnopparat, N., Ingkatawornwong, S., 1999. Properties of soliddispersions of piroxicam in polyvinylpyrrolidone, Int. J. Pharm, 1 8 1 ,1 4 3 -1 5 1 .

Tashtoush, B.M., Al-Qashi, Z.S., Najib, N.M., 2004, In vitro and in vivo evaluation ofglibenclamide in solid dispersion systems. Drug Dev, Ind, Pharm, 30 ,6 0 1 -6 0 7 .

Taylor, L.S., Zografi, G., 1997, Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 ,1691 -1698 .

Taylor, L.S., Zografi, G., 1998, The quantitative analysis of crystallinity using FT-Ram an spectroscopy. Pharm. Res. 15(5), 755-761.

361

Teagarden, D.L,, Baker, D.S., 2002, Practical aspects of lyophilizafion using non-aqueous co­solvent systems. Eur. J, Pharm. Scl. 15(2), 115 -3^

Thakkar, A.L„ Hirsch, C.A., Page, J.G., 1977. Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative. J, Pharm. Pharmacol. 29, 783-784.

The United States Pharmacopoeia, XXIII, National Formulary XVIII, 1995. Asian edition, US Pharmacopoeial Convention, Inc., Rockville, MD, 267.

Timko, R.J., Lordi, N.G., 1984. Thermal analysis studies of glass dispersion systems. Drug Dev. Ind. Pharm. 10(3), 425-451.

Tobyn, M,, Brown, J., Dennis, A.B., Fakes, M., Gao, Q., Gamble, J., Khimyak, Y .Z., McGeorge,G., Patel, 0 ., Sinclair, W „ Timmins, P., Yin, S., 2009. Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. J. Pharm, Sci. 98(9), 3456-3468.

Torchilin, V.P., 2001. Structure and design of polymeric surfactant-based drug delivery systems. J, Contr, Rel. 73(2-3), 137-72.

Torrado, S,, Torrado, S,, Torrado, J.J,, Cadorniga, R,, 1996, Preparation dissolution and characterization of albendazole solid dispersions, Int. J. Pharm, 140, 247-250.

Tran, T.T,, Tran, P.H., Lee, B.J., 2009, Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug, Eur, J, Pharm. Biopharm. 72(1), 83-90.

Tran, T.T., Tran, P.M., Choi, H.G., Han, H.K., Lee, B.J., 2010. The roles of acidifiers in solid dispersions and physical mixtures. Int J Pharm. 2010;384(1-2):60-6.

Trapani, G., Franco, M,, Latrofa, A,, Pantaleo, M ,R,, Provenzano, M,R,, Sanna, E., Maciocco, E., Liso, G„ 1999. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000, Int. J, Pharm. 5(1). 121-130.

Uchino, T,, Yasuno, N,, Yanagihara, Y., Suzuki, H,, 2007, Solid dispersion of spironolactone with porous silica prepared by the solvent method, Pharmazie. 62(8), 599-603,

Unga, J,, Tajarobi, F,, Norder, 0 „ Frenning, G,, Larsson, A,, 2009, Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions, Eur, J. Pharm, Biopharm, 73(2):260-268.

Usui, F„ Maeda, K,, Kusai, A„ Ikeda, M,, Nishimura, K,, Yamamoto, K„ 1997, Inhibitory effects of water-soluble polymers on precipitation of RS-8359, Int. J, Pharm. 154 ,59 -66 ,

Vadnere, M,K„ 1990, Coprecipitates and melts, in: J. Swarbrick, J,C, Boylan (Eds.), Encylopedia of Pharmaceutical Technology, Marcel Dekker, New York, NY, pp, 337 -3 5 2 ,

Valizadeh, H,, Zakeri-Milani, P., Barzegar-Jalali, M,, Mohammadi, G„ Danesh-Bahreini, M .A„ Adibkia, K,, Nokhodchi, A„ 2007, Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers, Drug Dev, Ind, Pharm, 33(1), 45-56.

____________________________________ ____________ C h ap ter 7

362

Van Eerdenbrugh, B., Van Speybroeck, M„ Mols, R„ Houthoofd, K., Martens, J.A., Froyen, L., Van Humbeeck, J,, Augustijns, P„ Van den Mooter, G., 2009 Itraconazole/TPGS/Aerosil200 solid dispersions: cliaracterization, physical stability and in vivo performance. Eur. J. Pharm. Sci. 38(3), 270-8,

van Laarhoven, J.A.H., Kruft, M.A.B., Vromans, H., 2002. In vitro release properties of etonogestrei and ethinyl estradiol from a contraceptive vaginal ring. Int. J, Pharm. 232, 163- 173,

van Laarhoven, J,A,H., Vromans, H,, 2002. Influence of supersaturation on the release properties of a controlled release device based on EVA co-polymers. Abstract Book, 7th European Symposium on Controlled Drug Delivery, Noordwijk aan Zee, Netherlands, pp. 133-135.

Varshosaz, J„ Faghihian, H., Rastgoo, K., 2006, Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Deliv. 13(4), 295-302.

Vasanthavada, M., Tong, W .Q., Joshi, Y., Kislalioglu, M.S., 2004. Phase behavior of amorphous molecular dispersions I: Determination o f the degree and mechanism of solid solubility. Pharm, Res, 21(9), 1598-606,

Vaugelade, C„ Rohmer, A.C,, Burel, F,, Belleney, J., Duclos, R,, Bunei, C., 2001. Progesterone freeze-dried systems in sublingual dosage form, Int. J. Pharm, 229(1-2), 67-73,

Veiga, M, D,, Escobar, C,, Bernard, M. J,, 1993, Dissolution behavior of drugs from binary and ternary systems. Int. J. Pharm, 93, 215-220,

Vera, N,, Veiga, M.D., Cadorniga, R., 1991. Solid dispersions of oxodipine/PEG 6000 characterization and dissolution study. S. T, P, Pharma Sci, 1 ,125-129 ,

Verreck, G„ Chun, l„ Peeters, J,, Rosenblatt, J„ Brewster, M ,E,, 2003. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res, 20(5), 810-7,

Vervaet, C,, Baert, L., Remon, J.P., 1995. Extrusion-spheronisation- a literature review. Int. J. Pharm, 116,131-146.

Vijaya Kumar, S.G,, Mishra, D.N., 2006. Preparation, characterization and in vitro dissolution studies of solid dispersion ofmeloxicam with PEG 6000. Yakugaku Zasshi, 126(8), 657-664.

Vincent, M,F,, Kazarian, S,G, Eckert, C.A., 1997, Tunable diffusion of D2O in C02-swollen poly(methyl methacrylate) films, AlChE. 43(7), 1838-1848.

Vippagunta, S.R., Maul, K.A., Tallavajhala, S., Grant, D J ., 2002. Solid-state characterization of nifedipine solid dispersions, Int. J: Pharm, 236(1-2), 111-23.

Vippagunta, S,R„ Wang, Z,, Hornung, S., Krill, S.L., 2007, Factors affecting the formation of eutectic solid dispersions and their dissolution behavior, J, Pharm. Sci. 96(2), 294-304. .

Visser, M,R„ Baert, L,, Klooster, G,, Schueller, L., Geldof, M„ Vanwelkenhuysen, I., de Kock,H,, De Meyer, S,, Frijllnk, H.W ., Rosier, J„ Hinrichs, W .L., 2010. Inulin solid dispersion technology to improve the absorption of the BOS Class IV drug TM C 240, Eur. J. Pharm.

___ _ _____ ___ ______ C h a p te r 7

363

C h a p te r 7

Biopharm, 74(2), 233-8.

Vyas, V„ Sancheti, P., Karekar, P., Shah, M„ Pore, Y., 2009. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta. Pharm. 59(4), 453-61.

Wacker, S., Soliva, M., Speiser, P., 1991. Injection molding as a suitable process for manufacturing solid dispersions or solutions, Pharmazeutische Industrie, 53, 853-856.

Walker, S.E., Ganley, J.A., Bedford, K„ Eaves, T„ 1980. The filling of molten and thixotropic formulations into hard gelatin capsules. J, Pharm. Pharmacol. 32(6), 389- 93.

Walking, W .D., 1994, Povidone, in: A, Wade, P.J, W eller (Eds.), Handbook of Pharmaceutical Excipitients, American Pharmaceutical Association/The Pharmaceutical Press, Washington, DC/London, pp. 392-399.

Wang, F., Hui, H., Barnes, T.J., Barnett, C., Prestidge, C.A., 20100xidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm. 7(1), 227-36.

Wang, W., 2000. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 ,1-60 .

Warren, D.B., Benameur, H., Porter, C.J., Pouton, C.W ., 2010. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility. J. Drug Target, [Epub ahead of print].

Watkins, P.B., 1997. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv. Drug Deliv. Rev. 27, 161-170.

Weuts, I., Kempen, D., Verreck, G., Decorte, A., Heymans, K., Peeters, J,, Brewster, M., Van den Mooter, G., 2005. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 59(1), 119- 26,

Wilcox, W,R., Friedenberg, R., Back, N., 1964, Zone melting of organic compounds. Chem. Rev. 64,187-220,

Wiley, G, J., Ullah, I., Agharkar, S.N., 1995. Development of a semiautomatic system for R&D and clinical use for liquidfilled hard gelatin encapsulation, Pharm. Technol. 72-76,

Wiranidchapong, G,, Tucker, LG., Rades, T„ Kulvanich, P., 2008. Miscibility and Interactions between 17beta-estradiol and Eudragit RS in solid dispersion, J, Pharm. Sci. 97(11), 4879- 4888.

Wu, K,, Li, J., Wang, W., Winstead, D.A.. 2009, Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisoivent, J, Pharm. Sci. 98(7), 2422-2431.

Xia, X.J., Tao, Z.H., Ren, Y,, Wang, R.Y., Liu, Y,L., 2008, Preparation and in vitro study of buagafuran solid dispersions, Yao Xue Xue Bao, 43(5), 548-552.

Xie, P., Xie, Y.M., Song, H., Song, X„ Zuo, Y.J., Qiu, Y., Tang, X.H., 2008. Preparation and dissolution in vitro of esomeprazole zinc solid dispersion. Sichuan Da Xue Xue Bao Yi Xue

3 6 4

C h a p te r 7

Ban, 39(4), 648-650.

Xie, Y,, Li, G,, Yuan, X,, Cai, Z,, Rong, R,, 2009. Preparation and in vitro evaluation of solid dispersions of total ffavones of Hippophae rhamnoides L. AAPS Pharin, Sci. Tech. 10(2), 631 - 40.

Xie, Y., Xie, P., Song, X., Tang, X„ Song, H„ 2008. Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics. Int. J. Pharm. 360(1-2), 53-57.

Xu, D.H., Wang, S., Mei, X.T., Luo, X.J., Xu, S,B„ 2008, Studies on solubility enhancement of curcumin by Polyvinylpyrrolidione K30. Zhong Yao Cai. 31(3), 438-442.

Xu, L., Li, S.M., Sunada, H., 2007. Preparation and evaluation of Ibuprofen solid dispersion systems with kollidon particles using a pulse combustion dryer system. Chem, Pharm. Bull. (Tokyo). 55(11), 1545-1550.

Yagi, N., Terashima, Y., Kenmotsu, H., Sekikawa, H., Takada, M., 1996. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrroiidone. Chem. Pharm, Bull. 44, 241-244.

Yalkowsky, S.H., 1999. Solubility and Solubilization in Aqueous Media. American Chemical Society and Oxford University Press, New York, pp. 61-69.

Yamamura, S., Rogers, J.A. 1996. Characterization and dissolution behavior of nifedipine and phosphatidylcholine binary systems. Int. J, Pharm, 130, 65-73.

Yang, J., Grey, K., Doney, J., 2010, An improved kinetics approach to describe the physical stability of amorphous solid dispersions, int, J, Pharm. 384(1-2), 24-31,

Yang, M„ Wang, P., Huang, C.Y., Ku, M.S., Liu, H., Gogos, C,, 2010, Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing. Int. J. Pharm. 395(1-2),53-61,

Yang, W „ Tam, J,, Miller, D.A., Zhou, J,, McConville, J.T., Johnston, K.P., Williams, R ,0 , 3rd,,2008. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Int. J, Pharm, 361(1-2), 177-88.

Yano, K., Kajiyama, A,, Hamada, M„ Yamamoto, K,, 1997, Constitution of colloidal particles formed from a solid dispersion system, Chem, Pharm. Bull. 45 ,133 9 -1 344 .

Yao, L., Deng, K.Y., Luo, J.B,, 2008. Preparation and in vitro dissolution of the solid dispersions of cinnamon oil. Nan Fang Yi Ke Da Xue Xue Bao, 2008;28(1):52-3.

Ye, G., Wang, S., Hang, P,W „ Chen, L„ Wang, C., 2007. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization. Int. J. Pharm. 337(1-2), 80-7.

Yoo. S.D., Lee. S.H., Kang, E., Jun, H., Jung, J.Y., Park, J.W ., Lee, K.H., 2000. Bioavailabiiity of itraconazole in rats and rabbits after administration of tablets containing solid dispersion particles. Drug Dev. Ind. Pharm. 26(1), 27-34,

Yoshioka, S., Carstensen, J,T,, 1990, Rational storage conditions for accelerated testing of

365

C h a p te r 7

stability of solid pharmaceuticals, J Pharm Sci. 79(10), 943-4,

Yoshioka, S,, Carstensen, J.T., 1990. Rational storage conditions for accelerated testing of stability of solid pharmaceuticals. J, Pharm, Sci, 79(10), 943-944,

Yuan, J„ Mao, S,, Shen, Q., Hou, S„ He, Y., 2009, Influence of solid dispersion technique combination on dissolution of tanshinone HA, Zhongguo Zhong Yao Za ZhI, 34(6), 685-689,

Yuasa, H., Ozeki, T,, Kanaya, Y., Oishi, K., 1993. Application of the solid dispersion method to the controlled release of medicine, Chem. Pharm, Bull, 41, 933 -936 ,

Zahedi, P., Lee, P.i., 2007, Solid molecular dispersions of poorly water-soluble drugs in poly(2- hydroxyethyl methacrylate) hydrogels. Eur, J. Pharm. Biopharm. 65(3), 320-328.

Zantac Capsules, Physicians' Desk Reference, 1997, Medical Economics Company: Montvale,

Zhang, F,, McGinity, J,W,, 1999, Properties of sustained-release tablets prepared by hot-melt extrusion, Pharm, Dev. Technol, 4 , 241 -250 ,

Zhang, J.Y,, Shen, Z.G,, Zhong, J„ Hu, T.T., Chen, J.F., Ma, Z .Q ., Yun, J., 2006. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int. J. Pharm. 323(1-2), 153-160.

Zheng, X., Yang, R., Tang, X,, Zheng, L„ 2007a. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev. Ind, Pharm. 33(7), 791-802.

Zheng, X„ Yang, R., Zhang, Y., Wang. Z„ Tang, X., Zheng, L., 2007b. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion. Drug Dev. Ind. Pharm. 33(7), 783-9,

Zhu, T,, Chiu, Y,, Doan, T,, Klein, C., Chang, M., Brun, S., Hanna, G., Awni, W „ 2005. New Tablet Formulation of Lopinavir/Ritonavir is Bioequivalent to the Capsule at a Dose 800/200 mg, 48 sup. Int, Conf, on Antimic. Agents & Chem., (ICAAC).

Zidan, A.S., Habib, M.J., Khan, M.A., 2008. Process analytical technology: nondestructive evaluation of cyclosporine A and phospholipid solid dispersions by near infrared spectroscopy and imaging. J, Pharm, Sci. 97(8), 3388-3399,

Zingone, G., Moneghini, M., Rupena, P., Vojnovic, D,, 1992. Characterization and dissolution study of solid dispersions of theophylline and indomethacin with PVPA/A copolymers, S,T,P, Pharm. Sci. 2 ,1 8 6 -1 9 2 ,

Zingone, G„ Rubessa, F., 1994, Release of carbamazepine from solid dispersions with polyvinylpyrrolidone/vinylacetate copolymer (PVP/PA), S.T.P. Pharma Sci. 4(2), 122-127,

366